Anteris Technologies Global Corp. Common Stock (AVR) is a publicly traded Healthcare sector company. As of May 21, 2026, AVR trades at $8.65 with a market cap of $736.88M and a P/E ratio of -3.72. AVR moved +12.08% today. Year to date, AVR is +80.33%; over the trailing twelve months it is +125.65%. Its 52-week range spans $2.34 to $8.79. Analyst consensus is strong buy with an average price target of $16.00. Rallies surfaces AVR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own AVR include Citadel Advisors. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Anteris Technologies Global Corp. Common Stock.
| Metric | Value |
|---|---|
| Price | $8.65 |
| Market Cap | $736.88M |
| P/E Ratio | -3.72 |
| EPS | $-2.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $8.79 |
| 52-Week Low | $2.34 |
| Volume | 243 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.85M |
| Net Income | $-95.19M |
| Gross Margin | 74.28% |
4 analysts cover AVR: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.00.